| Monoclonal antibodies inhibit prion replication and delay the development of prion disease AR White, P Enever, M Tayebi, R Mushens, J Linehan, S Brandner, ... Nature 422 (6927), 80-83, 2003 | 623 | 2003 |
| Exosomal microRNA signatures in multiple sclerosis reflect disease status S Ebrahimkhani, F Vafaee, PE Young, SSJ Hur, S Hawke, E Devenney, ... Scientific reports 7 (1), 14293, 2017 | 262 | 2017 |
| Vasculitic neuropathy: a clinical and pathological study SHB Hawke, L Davies, R Pamphlett, YP Guo, JD Pollard, JG McLeod Brain 114 (5), 2175-2190, 1991 | 210 | 1991 |
| The pseudotumor syndrome: disorders of cerebrospinal fluid circulation causing intracranial hypertension without ventriculomegaly I Johnston, S Hawke, M Halmagyi, C Teo Archives of neurology 48 (7), 740-747, 1991 | 189 | 1991 |
| Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function. S Riemersma, A Vincent, D Beeson, C Newland, S Hawke, ... The Journal of clinical investigation 98 (10), 2358-2363, 1996 | 183 | 1996 |
| Regional heterogeneity of cellular prion protein isoforms in the mouse brain V Beringue, G Mallinson, M Kaisar, M Tayebi, Z Sattar, G Jackson, ... Brain 126 (9), 2065-2073, 2003 | 165 | 2003 |
| The immunogenicity of intracerebral virus infection depends on anatomical site PG Stevenson, S Hawke, DJ Sloan, CR Bangham Journal of virology 71 (1), 145-151, 1997 | 148 | 1997 |
| Long-term persistence of activated cytotoxic T lymphocytes after viral infection of the central nervous system S Hawke, PG Stevenson, S Freeman, CRM Bangham Journal of Experimental Medicine 187 (10), 1575-1582, 1998 | 137 | 1998 |
| Incidence and prevalence of NMOSD in Australia and New Zealand W Bukhari, KM Prain, P Waters, M Woodhall, MOG Cullen, L Clarke, ... Journal of Neurology, Neurosurgery & Psychiatry 88 (8), 632-638, 2017 | 124 | 2017 |
| PrP glycoforms are associated in a strain-specific ratio in native PrPSc A Khalili-Shirazi, L Summers, J Linehan, G Mallinson, D Anstee, S Hawke, ... Journal of General Virology 86 (9), 2635-2644, 2005 | 99 | 2005 |
| Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination F Tea, JA Lopez, S Ramanathan, V Merheb, FXZ Lee, A Zou, D Pilli, ... Acta neuropathologica communications 7, 1-22, 2019 | 89 | 2019 |
| PrPSc binding antibodies are potent inhibitors of prion replication in cell lines V Beringue, D Vilette, G Mallinson, F Archer, M Kaisar, M Tayebi, ... Journal of Biological Chemistry 279 (38), 39671-39676, 2004 | 80 | 2004 |
| Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor. H Matsuo, AP Batocchi, S Hawke, M Nicolle, L Jacobson, A Vincent, ... Journal of immunology (Baltimore, Md.: 1950) 155 (7), 3683-3692, 1995 | 72 | 1995 |
| IgG monoclonal paraproteinaemia and peripheral neuropathy. AF Bleasel, SH Hawke, JD Pollard, JG McLeod Journal of Neurology, Neurosurgery & Psychiatry 56 (1), 52-57, 1993 | 71 | 1993 |
| Differential toxicity of antibodies to the prion protein RR Reimann, T Sonati, S Hornemann, US Herrmann, M Arand, S Hawke, ... PLoS pathogens 12 (1), e1005401, 2016 | 69 | 2016 |
| Autoimmune T cells in myasthenia gravis: heterogeneity and potential for specific immunotargeting S Hawke, H Matsuo, M Nicolle, G Malcherek, A Melms, N Willcox Immunology today 17 (7), 307-311, 1996 | 66 | 1996 |
| Phenobarbital compared with carbamazepine in prevention of recurrent febrile convulsions: a double-blind study JH Antony, SHB Hawke American Journal of Diseases of Children 137 (9), 892-895, 1983 | 66 | 1983 |
| Protein conformation significantly influences immune responses to prion protein A Khalili-Shirazi, S Quaratino, M Londei, L Summers, M Tayebi, ... The Journal of Immunology 174 (6), 3256-3263, 2005 | 58 | 2005 |
| Effect of social drinking on neuropsychological performance M WAUGH, M Jackson, GA Fox, SH Hawke, RR Tuck British Journal of Addiction 84 (6), 659-667, 1989 | 58 | 1989 |
| Immunotherapy as a therapeutic treatment for neurodegenerative disorders AR White, SH Hawke Journal of neurochemistry 87 (4), 801-808, 2003 | 52 | 2003 |